Blind Spot

Nora Harken can read people the way most analysts read data — patterns of behavior, cracks in a story, the tell that separates a liar from someone carrying a secret. It's a skill she built in Army Intelligence and sharpened into a career. It's also the skill that failed her when it mattered most.

Two years after the Ashland incident — a catastrophic intelligence failure that killed four of her colleagues and ended her military career — Nora runs a small risk-assessment consultancy in Washington, D.C. The work is steady and forgettable. Then a congressional staffer calls with a job that is neither.

A pharmaceutical whistleblower is set to testify before Congress in seventy-two hours. His testimony will expose a painkiller that's been killing patients, a cover-up that reaches the FDA, and a CEO who will do anything to stop it. A private security team is guarding the witness at a rural Virginia safehouse — but after a perimeter breach, the staffer no longer trusts her own people. She needs Nora to assess the detail and determine whether the threat is outside the walls or inside them.

Nora takes the job. Within hours, she finds what she's looking for: a gap in the surveillance coverage that's too precise to be accidental, a monitoring system disabled without a maintenance record, and a team leader whose behavior doesn't match his spotless record. Someone on the inside is passing intelligence to the people who want the witness dead — and the people behind the operation aren't amateurs. They're a network of former intelligence contractors who specialize in making problems disappear.

With the testimony clock running down and the opposition closing in, Nora must identify the compromised operator, understand why he turned, and find a way to get her witness to the hearing alive. But the deeper she digs, the more the case begins to echo the failure she's spent two years trying to forget — and the answers she uncovers may reach far beyond a single whistleblower or a single betrayal.